Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 13/20 | 0.72 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.72 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.72 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10438001 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5ENPP2 | |
| SCHEMBL10437957 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5ENPP2 | |
| SCHEMBL10437941 | 1.00 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5ENPP2 | |
| SCHEMBL10437935 | 0.90 | LPAR3 (0.56) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL8977037 | 0.90 | LPAR3 (0.56) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL10438011 | 0.90 | LPAR3 (0.56) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL10438607 | 0.90 | LPAR3 (0.56) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL10435482 | 0.90 | LPAR3 (0.56) | LPAR3LPAR2LPAR1LPAR5 | |
| Hexadecyl Dihydrogen Phosphate SCHEMBL9365300 | 0.86 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5ENPP2 | |
| SCHEMBL29098363 | 0.86 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR5ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513174-B2 | Cleanser | SHISEIDO COMPANY LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| EP-2251403-B1 | CLEANSING COMPOSITION | SHISEIDO CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20100317555-A1 | Cleanser | SHISEIDO COMPANY LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| EP-2251403-A1 | CLEANSING COMPOSITION | Shiseido Company, Ltd. (JP) | 2010-11-17 | — | — | EP | disclosed |
| EP-0442701-B1 | Topical composition | UNILEVER PLC (GB) | 1996-04-24 | — | — | EP | disclosed |
| EP-0371803-A1 | Topical composition | UNILEVER PLC (GB) | 1990-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317555-A1 | Cleanser | STS, SGMS1, PTDSS1 | LPAR3 1373/4885LPAR2 1267/4885LPAR1 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.